We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Simple Blood Test Identifies Organs Likely to Fail First

By LabMedica International staff writers
Posted on 07 Dec 2023
Print article
Image: A new study has found a way to predict which of our organs will fail first (Photo courtesy of illustratoren.de/TobiasWuestefeld)
Image: A new study has found a way to predict which of our organs will fail first (Photo courtesy of illustratoren.de/TobiasWuestefeld)

Similar to a typical car or house or society, the speed at which parts of the human body fall apart differs from part to part. In a groundbreaking study, researchers have developed a novel method to analyze organ aging by examining specific proteins or sets of proteins in the blood. This approach can predict an individual's risk for various diseases.

Investigators at Stanford Medicine (Stanford, CA, USA) conducted a study involving 5,678 participants that revealed organ age at varying rates. The research found that when an organ is significantly older than what is typical for a person's chronological age, that individual faces an increased risk for diseases related to that organ, as well as a higher mortality risk. The study found that approximately 20% of healthy adults over 50 have at least one organ aging much faster than normal. This finding suggests that a simple blood test could identify which organs in a person are aging rapidly, potentially allowing for early intervention before symptoms appear. Previous studies have generated single numbers to represent biological age, contrasting with chronological age. However, this new research assigns specific aging numbers to 11 key organs and systems: the heart, fat, lung, immune system, kidney, liver, muscle, pancreas, brain, vasculature, and intestine.

The researchers utilized available technologies and a unique algorithm to measure thousands of blood proteins, identifying nearly 1,000 proteins linked to specific organs. Abnormal protein levels were associated with accelerated aging of corresponding organs, increasing susceptibility to disease and death. They calculated an "age gap" for each organ, representing the difference between its actual and algorithm-predicted age. The study found significant associations between these age gaps and future mortality risk over 15 years, except for the intestine. An accelerated-aging organ, defined as having a biological age one standard deviation higher than the average for that organ in people of the same chronological age, was associated with a 15% to 50% increased mortality risk over the following 15 years.

The study also found that accelerated heart aging significantly increased the risk of heart failure, while older brains correlated with a higher likelihood of cognitive decline. Accelerated aging in the brain or vasculature was a strong predictor of Alzheimer’s disease progression. Additionally, there were clear connections between extremely aged kidneys and conditions like hypertension and diabetes, as well as between aged hearts and atrial fibrillation or heart attacks. The identification of organ-specific proteins that indicate excessive aging could also lead to new therapeutic targets, paving the way for drug development and more personalized medical interventions.

“We can estimate the biological age of an organ in an apparently healthy person,” said the study’s senior author, Tony Wyss-Coray, PhD, a professor of neurology and the D. H. Chen Professor II. “That, in turn, predicts a person’s risk for disease related to that organ.”

Related Links:
Stanford Medicine

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: The mass spectrometer can detect different structures of the sugar molecules, called glycans, in cells (Photo courtesy of Lundbergs forskningsstiftelse/Magnus Gotander)

AI Model Detects Cancer at Lightning Speed through Sugar Analyses

Glycans, which are structures made up of sugar molecules within cells, can be analyzed using mass spectrometry. This technique is particularly useful because these sugar structures can reveal the presence... Read more

Hematology

view channel
Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA)

New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds

HORIBA (Kyoto, Japan) has expanded its line of compact hematology analyzers by introducing new models that incorporate Erythrocyte Sedimentation Rate (ESR) measurement capabilities. The newly launched... Read more

Pathology

view channel
Image: The new test helps differentiate a B-cell cancer from a normal, reactive immune response (Photo courtesy of Roche)

New Highly-Sensitive Test to Help More Easily Diagnose B-Cell Lymphoma

B-cell lymphoma, a cancer primarily originating in the lymphatic system, represents about 85% of non-Hodgkin lymphoma (NHL) diagnoses. NHL ranks as the tenth most prevalent cancer globally, claiming over... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.